REGULATED PRESS RELEASE published on 10/01/2025 at 18:15, 2 months 3 days ago Financial statements - 30 june 2025
BRIEF published on 09/23/2025 at 18:20, 2 months 11 days ago EXACOMPTA CLAIREFONTAINE Reports Decrease in H1 2025 Profits Financial Results Market Challenges Revenue Decline Operating Income Management Changes
REGULATED PRESS RELEASE published on 09/23/2025 at 18:15, 2 months 11 days ago Financial statements - 30 june 2025 EXACOMPTA CLAIREFONTAINE Board of Directors reviewed and approved Group financial statements for H1 2025 in Paris. Revenue down, operating income dropped, economic challenges noted Financial Statements Revenue Operating Income Exacompta Clairefontaine Economic Conditions
BRIEF published on 09/18/2025 at 18:20, 2 months 16 days ago EXACOMPTA CLAIREFONTAINE 2025 half-year report: declining results Half-year Results Turnover General Management Financial Debt Outlook 2025
REGULATED PRESS RELEASE published on 05/13/2025 at 18:11, 6 months 22 days ago DPEF - non financial performance declaration 2024
BRIEF published on 04/02/2025 at 18:10, 8 months 2 days ago EXACOMPTA CLAIREFONTAINE Reports 2024 Financial Results Market Conditions Revenue Decline Segment Performance Financial Results 2024 2025 Outlook
REGULATED PRESS RELEASE published on 04/02/2025 at 18:05, 8 months 2 days ago Financial statements - 31 december 2024 EXACOMPTA CLAIREFONTAINE Board of Directors approved 2024 financial statements. Revenue: €831,274,000. Outlook cautious due to weak Q1 2025 demand Financial Statements Revenue Outlook 2024 Exacompta Clairefontaine
BRIEF published on 03/27/2025 at 18:05, 8 months 8 days ago EXACOMPTA CLAIREFONTAINE: 2024 annual results and 2025 outlook Stationery Market 2024 Results Outlook 2025 Dividend Share Paper Production
BRIEF published on 03/03/2025 at 18:05, 9 months 1 day ago Voting Rights and Shares 2024: Exacompta Clairefontaine Report Share Capital Voting Rights Actions Financial Market Exacompta Clairefontaine
Published on 12/05/2025 at 02:35, 1 hour 57 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 32 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 27 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 32 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 1 minute ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 41 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 6 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 17 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 21 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 32 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 47 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 47 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 31 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025